Development and Validation of a UHPLC–MS/MS Method for the Quantification of a Novel PYGB Inhibitor in Plasma: Application to Pharmacokinetic Studies
In previous studies, we reported compound <b>1</b> (5-chloro-<i>N</i>-(4-oxo-2,2-dipropyl-3,4-dihydro-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-6-yl)-1<i>H</i>-indole-2-carboxamide) as a novel PYGB inhibitor, and found that it had better anti-is...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-10-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/28/19/6995 |